The FDA has granted Kips Bay Medical investigational device exemption approval to test the use of its eSVS mesh in patients undergoing coronary artery bypass graft surgery. The conditional approval allows the company to add four U.S. clinical sites to an ongoing clinical trial of the device, which is used during CABG procedures to aid in keeping vein grafts open.
FDA approves U.S. study of Kips Bay Medical's surgical mesh
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||